Restarting Trazodone at 50mg After 2-Month Discontinuation
Yes, you can restart trazodone at 50mg in this 15-year-old patient, though it's important to note that trazodone is not recommended as a first-line treatment for insomnia based on current evidence.
Key Considerations
Evidence Against Trazodone for Insomnia
The 2017 American Academy of Sleep Medicine guideline explicitly recommends against using trazodone for sleep onset or sleep maintenance insomnia 1. In the single controlled trial of trazodone 50mg, improvements in sleep latency (10 minutes), total sleep time (22 minutes), and wake after sleep onset (8 minutes) all fell below clinically significant thresholds 1. Additionally, 75% of patients experienced adverse events, with headache (30%) and somnolence (23%) being most common 1.
Practical Dosing Approach
Despite the limited evidence for efficacy, if you choose to restart trazodone:
- Starting dose of 50mg at bedtime is appropriate after a 2-month washout period
- The patient previously tolerated 150mg, so 50mg represents a conservative restart dose
- No gradual titration is required when restarting at this lower dose
- The NCCN palliative care guideline lists trazodone 25-100mg at bedtime as an option for insomnia 2
Drug Interaction Considerations
The combination of escitalopram 10mg + dexmethylphenidate ER 20mg + trazodone 50mg appears safe:
- Escitalopram and trazodone are both serotonergic agents, creating theoretical serotonin syndrome risk, but this is uncommon at these doses 3
- Dexmethylphenidate has minimal drug interactions with SSRIs or trazodone 4
- Monitor for increased sedation, as both escitalopram and trazodone can cause somnolence
- The combination of SSRI + stimulant has demonstrated safety in adolescent ADHD with comorbid depression 5
Alternative Considerations
Given the weak evidence for trazodone, consider discussing with the patient/family:
- Behavioral sleep interventions (sleep hygiene, stimulus control) should be first-line
- If pharmacotherapy is needed, other options with better evidence include low-dose doxepin (3-6mg) for sleep maintenance 1
- Address whether stimulant timing or dose contributes to insomnia—dexmethylphenidate ER should be given in the morning to minimize sleep disruption 4
Monitoring Plan
After restarting trazodone 50mg:
- Assess sleep improvement within 1-2 weeks
- Monitor for daytime sedation, headache, dizziness
- Watch for mood changes or increased irritability
- If ineffective at 50mg after 2 weeks, can increase to 100mg, though evidence doesn't support doses beyond this
- Periodically reassess need for continued treatment
The 2-month gap does not require special precautions for restarting at 50mg, as this is well below the previous 150mg dose and trazodone doesn't require gradual titration when initiating.